1088 related articles for article (PubMed ID: 17950381)
21. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
22. Hereditary ovarian cancer.
Langston AA; Ostrander EA
Curr Opin Obstet Gynecol; 1997 Feb; 9(1):3-7. PubMed ID: 9090474
[TBL] [Abstract][Full Text] [Related]
23. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
24. [From gene to disease; from DNA 'mismatch' repair genes to hereditary non-polyposis colorectal carcinoma].
Wijnen JT; Morreau H; Vasen HF
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):780-2. PubMed ID: 11346916
[TBL] [Abstract][Full Text] [Related]
25. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
26. [Genetic predisposition and ovarian cancer].
Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D
Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879
[TBL] [Abstract][Full Text] [Related]
27. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary non polyposis colorectal cancer].
Dieumegard B
Ann Med Interne (Paris); 2001 Sep; 152(5):317-21. PubMed ID: 11593143
[TBL] [Abstract][Full Text] [Related]
29. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
30. Considerations in genetic counseling for inherited breast cancer predisposition.
Robson ME; Offit K
Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
[TBL] [Abstract][Full Text] [Related]
31. Hereditary colorectal cancer syndromes.
Strate LL; Syngal S
Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
[TBL] [Abstract][Full Text] [Related]
32. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
Ballinger LL
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
[TBL] [Abstract][Full Text] [Related]
33. Advances in the understanding of risk factors for ovarian cancer.
Bandera CA
J Reprod Med; 2005 Jun; 50(6):399-406. PubMed ID: 16050564
[TBL] [Abstract][Full Text] [Related]
34. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.
Swisher E
Curr Womens Health Rep; 2003 Feb; 3(1):27-32. PubMed ID: 12521547
[TBL] [Abstract][Full Text] [Related]
36. Hereditary ovarian cancer: molecular genetics and clinical implications.
Boyd J; Rubin SC
Gynecol Oncol; 1997 Feb; 64(2):196-206. PubMed ID: 9038264
[TBL] [Abstract][Full Text] [Related]
37. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
Kauff ND; Barakat RR
J Clin Oncol; 2007 Jul; 25(20):2921-7. PubMed ID: 17617523
[TBL] [Abstract][Full Text] [Related]
38. The genetics of hereditary colon cancer.
Rustgi AK
Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
[TBL] [Abstract][Full Text] [Related]
39. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Roukos DH; Briasoulis E
Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
[TBL] [Abstract][Full Text] [Related]
40. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
Prucka SK; McIlvried DE; Korf BR
Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]